Nuclear receptor SET domain-containing protein-1 (NSD1) silencing by epigenetic modification leads to Sotos syndrome, as well as nonhereditary neuroblastoma and glioma development (Berdasco et al., 2009). This evidence concerns the gene NSD1 and glioma.